Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Pharmacological Preconditioning"”.

  1. The role of signal transducer and activator of transcription-3 (STAT-3) in ischaemic and pharmacological preconditioning

    Ischemic preconditioning is a protective mechanism whereby repetitive transient ischaemia confer protection against the subsequent prolonged lethal ischaemia that is observed during myocardial infarction. This protective phenomenon that lessens myocardial infarction can be mimicked by the cytokine …

    cape-town Repository record for The role of signal transducer and activator of transcription-3 (STAT-3) in ischaemic and pharmacological preconditioning (opens in a new tab)

  2. Novel Strategies in Cardioprotection against Ischemia/Reperfusion Injury

    … been made towards identifying physiological and pharmacological agents that play a key role in myocardial preconditioning against I/R injury and also elucidating the molecular changes leading to such protection.Second messengers in cellular signaling pathways, such as cGMP have been well …

    vcu Repository record for Novel Strategies in Cardioprotection against Ischemia/Reperfusion Injury (opens in a new tab)

  3. Myocardial ischemia-reperfusion and cardioprotection. A study with microdialysis in a porcine model.

    … have been debated. Beta-blockers may inhibit the pharmacological preconditioning elicited by volatile anaesthetics. In the third study, it was demonstrated that levosimendan, in the presence of beta-blockade, was still able to induce a cardioprotective effect on the myocardial ischemic metabolism. …

    lund Repository record for Myocardial ischemia-reperfusion and cardioprotection. A study with microdialysis in a porcine model. (opens in a new tab)

  4. PATHOGENIC ROLE OF PHOSPHODIESTERASE TYPE 5 UPREGULATION IN CARDIAC ISCHEMIA/REPERFUSION INJURY

    Phosphodiesterase Type 5 (PDE5) inhibitors are cardioprotective against ischemia/reperfusion (I/R) injury. However, it remains uncertain if I/R affects PDE5. We hypothesized that generation of reactive oxygen species (ROS) during I/R leads to upregulation of PDE5, which contributes to pathological …

    vcu Repository record for PATHOGENIC ROLE OF PHOSPHODIESTERASE TYPE 5 UPREGULATION IN CARDIAC ISCHEMIA/REPERFUSION INJURY (opens in a new tab)